Titre : Virus de la fièvre jaune

Virus de la fièvre jaune : Questions médicales fréquentes

Termes MeSH sélectionnés :

Facilities and Services Utilization
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Virus de la fièvre jaune : Questions médicales les plus fréquentes", "headline": "Virus de la fièvre jaune : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Virus de la fièvre jaune : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-17", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Virus de la fièvre jaune" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavivirus", "url": "https://questionsmedicales.fr/mesh/D005416", "about": { "@type": "MedicalCondition", "name": "Flavivirus", "code": { "@type": "MedicalCode", "code": "D005416", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.578.344.350" } } }, "about": { "@type": "MedicalCondition", "name": "Virus de la fièvre jaune", "alternateName": "Yellow fever virus", "code": { "@type": "MedicalCode", "code": "D015005", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Betânia Paiva Drumond", "url": "https://questionsmedicales.fr/author/Bet%C3%A2nia%20Paiva%20Drumond", "affiliation": { "@type": "Organization", "name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil." } }, { "@type": "Person", "name": "Marta Giovanetti", "url": "https://questionsmedicales.fr/author/Marta%20Giovanetti", "affiliation": { "@type": "Organization", "name": "Laboratório de Flavivírus, Instituto Oswaldo Cruz Fiocruz, Rio de Janeiro, Brazil giovanetti.marta@gmail.com." } }, { "@type": "Person", "name": "Pedro Augusto Alves", "url": "https://questionsmedicales.fr/author/Pedro%20Augusto%20Alves", "affiliation": { "@type": "Organization", "name": "Instituto René Rachou/Fundação Oswaldo Cruz, 30190-002 Belo Horizonte, Minas Gerais, Brazil." } }, { "@type": "Person", "name": "Matheus Soares Arruda", "url": "https://questionsmedicales.fr/author/Matheus%20Soares%20Arruda", "affiliation": { "@type": "Organization", "name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil." } }, { "@type": "Person", "name": "Gabriela Fernanda Garcia Oliveira", "url": "https://questionsmedicales.fr/author/Gabriela%20Fernanda%20Garcia%20Oliveira", "affiliation": { "@type": "Organization", "name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The 5-year longitudinal diagnostic profile and health services utilization of patients treated with electroconvulsive therapy in Quebec: a population-based study.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36163429", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00127-022-02369-w" } }, { "@type": "ScholarlyArticle", "name": "Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study.", "datePublished": "2023-07-15", "url": "https://questionsmedicales.fr/article/37517875", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clml.2023.07.006" } }, { "@type": "ScholarlyArticle", "name": "The relationship between home and community-based healthcare services utilization and depressive symptoms in older adults in rural China: a moderated mediation model.", "datePublished": "2023-05-30", "url": "https://questionsmedicales.fr/article/37254084", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-15590-2" } }, { "@type": "ScholarlyArticle", "name": "Estimating the effects of COVID-19 on essential health services utilization in Uganda and Bangladesh using data from routine health information systems.", "datePublished": "2023-09-27", "url": "https://questionsmedicales.fr/article/37829090", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2023.1129581" } }, { "@type": "ScholarlyArticle", "name": "Area-specific covid-19 effects on health services utilization in the Democratic Republic of the Congo using routine health information system data.", "datePublished": "2023-06-03", "url": "https://questionsmedicales.fr/article/37270545", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-09547-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Virus", "item": "https://questionsmedicales.fr/mesh/D014780" }, { "@type": "ListItem", "position": 3, "name": "Virus à ARN", "item": "https://questionsmedicales.fr/mesh/D012328" }, { "@type": "ListItem", "position": 4, "name": "Virus à ARN à brin positif", "item": "https://questionsmedicales.fr/mesh/D000085102" }, { "@type": "ListItem", "position": 5, "name": "Flaviviridae", "item": "https://questionsmedicales.fr/mesh/D018067" }, { "@type": "ListItem", "position": 6, "name": "Flavivirus", "item": "https://questionsmedicales.fr/mesh/D005416" }, { "@type": "ListItem", "position": 7, "name": "Virus de la fièvre jaune", "item": "https://questionsmedicales.fr/mesh/D015005" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Virus de la fièvre jaune - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Virus de la fièvre jaune", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Virus de la fièvre jaune", "description": "Comment diagnostique-t-on la fièvre jaune ?\nQuels tests sont utilisés pour la fièvre jaune ?\nQuand faire un test pour la fièvre jaune ?\nPeut-on confondre la fièvre jaune avec d'autres maladies ?\nQuels sont les symptômes initiaux de la fièvre jaune ?", "url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Virus de la fièvre jaune", "description": "Quels sont les symptômes de la fièvre jaune ?\nLa fièvre jaune cause-t-elle des saignements ?\nQuels signes indiquent une forme sévère ?\nCombien de temps durent les symptômes ?\nY a-t-il des symptômes spécifiques chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Virus de la fièvre jaune", "description": "Comment prévenir la fièvre jaune ?\nQui doit se faire vacciner contre la fièvre jaune ?\nQuels sont les effets secondaires du vaccin ?\nComment éviter les piqûres de moustiques ?\nLe vaccin est-il efficace immédiatement ?", "url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Virus de la fièvre jaune", "description": "Quel est le traitement de la fièvre jaune ?\nComment gérer la déshydratation due à la fièvre jaune ?\nDes médicaments peuvent-ils aider ?\nLa transfusion sanguine est-elle nécessaire ?\nPeut-on utiliser des antibiotiques pour la fièvre jaune ?", "url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Virus de la fièvre jaune", "description": "Quelles sont les complications possibles de la fièvre jaune ?\nLa fièvre jaune peut-elle être mortelle ?\nQuels facteurs augmentent le risque de complications ?\nComment se manifeste l'insuffisance hépatique ?\nY a-t-il des séquelles après la fièvre jaune ?", "url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Virus de la fièvre jaune", "description": "Qui est le plus à risque de contracter la fièvre jaune ?\nLes voyageurs doivent-ils se préoccuper de la fièvre jaune ?\nLes personnes non vaccinées sont-elles plus vulnérables ?\nLes enfants sont-ils plus à risque ?\nLes personnes âgées sont-elles plus à risque ?", "url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la fièvre jaune ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sérologiques et PCR pour détecter le virus." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la fièvre jaune ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques IgM et IgG ainsi que la PCR sont couramment utilisés." } }, { "@type": "Question", "name": "Quand faire un test pour la fièvre jaune ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les tests doivent être effectués dès l'apparition des symptômes, généralement dans les 7 jours." } }, { "@type": "Question", "name": "Peut-on confondre la fièvre jaune avec d'autres maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec la dengue ou le paludisme en raison de symptômes similaires." } }, { "@type": "Question", "name": "Quels sont les symptômes initiaux de la fièvre jaune ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes initiaux incluent fièvre, frissons, douleurs musculaires et céphalées." } }, { "@type": "Question", "name": "Quels sont les symptômes de la fièvre jaune ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, douleurs musculaires, nausées, et jaunisse." } }, { "@type": "Question", "name": "La fièvre jaune cause-t-elle des saignements ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des saignements peuvent survenir, notamment des saignements gastro-intestinaux." } }, { "@type": "Question", "name": "Quels signes indiquent une forme sévère ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une jaunisse, des douleurs abdominales et des saignements sont des signes de gravité." } }, { "@type": "Question", "name": "Combien de temps durent les symptômes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent durer de quelques jours à deux semaines, selon la gravité." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les enfants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants présentent des symptômes similaires, mais peuvent avoir des manifestations plus sévères." } }, { "@type": "Question", "name": "Comment prévenir la fièvre jaune ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination est la méthode la plus efficace pour prévenir la fièvre jaune." } }, { "@type": "Question", "name": "Qui doit se faire vacciner contre la fièvre jaune ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les voyageurs vers des zones à risque et les personnes vivant dans ces zones doivent se vacciner." } }, { "@type": "Question", "name": "Quels sont les effets secondaires du vaccin ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure fièvre légère, douleurs au site d'injection, et fatigue." } }, { "@type": "Question", "name": "Comment éviter les piqûres de moustiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des répulsifs, portez des vêtements longs et installez des moustiquaires." } }, { "@type": "Question", "name": "Le vaccin est-il efficace immédiatement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le vaccin confère une protection après 10 jours, mais l'immunité dure plusieurs années." } }, { "@type": "Question", "name": "Quel est le traitement de la fièvre jaune ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer la déshydratation due à la fièvre jaune ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation par voie intraveineuse est essentielle pour traiter la déshydratation." } }, { "@type": "Question", "name": "Des médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des analgésiques et antipyrétiques peuvent être utilisés pour soulager les symptômes." } }, { "@type": "Question", "name": "La transfusion sanguine est-elle nécessaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une transfusion peut être nécessaire en cas de saignements sévères ou d'anémie." } }, { "@type": "Question", "name": "Peut-on utiliser des antibiotiques pour la fièvre jaune ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les virus, y compris le virus de la fièvre jaune." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la fièvre jaune ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance hépatique, les saignements et le choc." } }, { "@type": "Question", "name": "La fièvre jaune peut-elle être mortelle ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre jaune peut être mortelle, surtout sans traitement approprié." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies préexistantes et l'absence de vaccination augmentent le risque." } }, { "@type": "Question", "name": "Comment se manifeste l'insuffisance hépatique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une jaunisse, des douleurs abdominales et des troubles de la coagulation." } }, { "@type": "Question", "name": "Y a-t-il des séquelles après la fièvre jaune ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines personnes peuvent avoir des séquelles hépatiques ou neurologiques après la maladie." } }, { "@type": "Question", "name": "Qui est le plus à risque de contracter la fièvre jaune ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes vivant ou voyageant dans des zones endémiques sont les plus à risque." } }, { "@type": "Question", "name": "Les voyageurs doivent-ils se préoccuper de la fièvre jaune ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyageurs vers des régions à risque doivent être vaccinés et informés." } }, { "@type": "Question", "name": "Les personnes non vaccinées sont-elles plus vulnérables ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'absence de vaccination augmente considérablement le risque d'infection." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent être plus vulnérables aux complications graves de la fièvre jaune." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de complications sévères liées à la fièvre jaune." } } ] } ] }

Sources (10000 au total)

The 5-year longitudinal diagnostic profile and health services utilization of patients treated with electroconvulsive therapy in Quebec: a population-based study.

Electroconvulsive therapy (ECT) is effective for treating several psychiatric disorders. However, only a minority of patients are treated with ECT. It is of primary importance to characterize their pr... We conducted a population-based comparative study using data from a national administrative database in Quebec. Patients who received a first ECT between 2002 and 2016 were compared to controls who we... 5 080 ECT patients were compared with 179 594 controls. Depressive, anxiety, bipolar and psychotic disorders were more frequent in the ECT group. 96.2% of ECT patients had been diagnosed with depressi... Our results provide robust evidence of complex longitudinal psychopathology and extensive services utilization among ECT patients....

Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study.

Most patients with multiple myeloma (MM) relapse or become refractory, resulting in high health care costs. However, real-world data regarding the utilization of health care services among the relapse... Observational, cross-sectional, multicenter study of the utilization of health care services by RRMM patients who had relapsed within the previous 6 months in Spain in a real-world setting. Data were ... The 276 patients enrolled (53.3% males), with a mean [SD] age of 67.4 [10.5] years, had experienced their most recent relapse a median (IQR) of 1.61 (0.74, 3.14) months before entering the study. Pati... RRMM treatments are associated with a high utilization of health care services and pose a significant burden for patients and caregivers.... NCT03188536....

The relationship between home and community-based healthcare services utilization and depressive symptoms in older adults in rural China: a moderated mediation model.

Studies have shown a close association between home and community-based healthcare services (HCBHS) utilization and depressive symptoms in older adults. However, no studies have explored the underlyin... Data were obtained from the 2018 China Health and Retirement Longitudinal Study, and 5,981 rural respondents (≥ 60 years old) were included. Depression scores were calculated using the ten-item Center... HCBHS utilization had a direct and negative effect on depressive symptoms. Furthermore, marital status moderated the association between HCBHS utilization and IADL, which belonged to the indirect infl... The results demonstrated that marital status moderated the indirect relationship between HCBHS utilization and depressive symptoms, with HCBHS utilization being negatively associated with IADL among s...

Estimating the effects of COVID-19 on essential health services utilization in Uganda and Bangladesh using data from routine health information systems.

Since March 2020, the coronavirus disease 2019 (COVID-19) pandemic has been a major shock to health systems across the world. We examined national usage patterns for selected basic, essential health s... We used routine health information system data since January 2017 to analyze reporting and service utilization patterns for a variety of health services. Using time series models to replicate pre-COVI... The time trend models for Uganda and Bangladesh closely replicated the levels and trajectories of service utilization during the 38 months prior to the COVID-19 pandemic. Our results indicate that COV... Our analytical approach based on national information system data could be very useful as a form of surveillance for health services disruptions from any cause leading to rapid responses from health s...

Area-specific covid-19 effects on health services utilization in the Democratic Republic of the Congo using routine health information system data.

Since March 2020, the COVID-19 pandemic has shocked health systems worldwide. This analysis investigated the effects of the pandemic on basic health services utilization in the Democratic Republic of ... We estimated time trends models using national health information system data to replicate pre-COVID-19 (i.e., January 2017-February 2020) trajectories of health service utilization, and then used tho... Our results indicate that COVID-19 negatively impacted health services and subsequent recovery varied by service type and by geographical area. COVID-19 had a lasting impact on overall service utiliza... The methodology used in this article allows for examining the variability in magnitude, timing, and duration of the COVID effects within geographical areas of the DRC and nationally. This analytical p...

Did Access to Ambulatory Care Moderate the Associations Between Visit Mode and Ancillary Services Utilization Across the COVID-19 Pandemic Period?

In recent years, 2 circumstances changed provider-patient interactions in primary care: the substitution of virtual (eg, video) for in-person visits and the COVID-19 pandemic. We studied whether acces... Data were extracted from the electronic health records of 3 Kaiser Permanente Regions to identify incident NBP and UTI visits from January 2016 through June 2021. Visit modes were classified as virtua... For diagnostic radiology, laboratory, and pharmacy services, percentages of fulfilled orders were generally >70-80%. Given an incident NBP or UTI visit, longer distance to the clinic and higher cost-s... Distance to the clinic or HDHP enrollment had minimal impact on the fulfillment of diagnostic or prescribed medication services associated with incident NBP or UTI visits delivered virtually or in-per...

Association between Primary Care Utilization and Emergency Room or Hospital Inpatient Services Utilization among the Middle-Aged and Elderly in a Self-Referral System: Evidence from the China Health and Retirement Longitudinal Study 2011-2018.

With rapid economic growth and aging, hospital inpatient and emergency services utilization has grown rapidly, and has emphasized an urgent requirement to adjust and optimize the structure of health s...

Opioid prescriptions and patients' health services utilization and cost before and during the COVID-19 pandemic: an exploratory population-based administrative data analysis.

The objective was to explore percentages of the population treated with prescribed opioids and costs of opioid-related hospitalizations and emergency department (ED) visits among individuals treated w...

Health services utilization and associated factors among fee waiver beneficiaries' in Dessie city administration, Northeast Ethiopia: a cross-sectional study design.

The fee waiver system is one of the components of the 2004 health care financing reform in Ethiopia. It is a system for granting access to health services to those who are unable to pay. The utilizati... A community-based cross-sectional study design was employed in Dessie City from March 23 to April 23, 2021. The study was conducted among 407 fee waiver beneficiaries. A structured, interviewer-admini... The overall health service utilization among fee waiver beneficiaries was found to be 62.4% (95% CI: 58.1-67.2). Being an urban resident [AOR:2.83, 95% CI:1.26-6.32], having a merchant occupation [AOR... The fee waiver beneficiaries were not fully utilizing health services at public health facilities. Being an urban resident, being a merchant, having an average monthly income of 500-1000 birr, having ...

Missed Opportunity of Antenatal Care Services Utilization and Associated Factors among Reproductive Age Women in Eastern Hararghe Zone, Eastern Ethiopia: Mixed Methods Study.

Despite the enormous advantages of early pregnancy-related problem diagnosis and therapy during prenatal care visits, not all pregnant women begin antenatal care at the proper time. Thus, this study a... A mixed methods study design (quantitative and qualitative) was conducted in Grawa, Meta, and Haramaya woredas from September 5 to December 5, 2019. The quantitative data were analyzed using SPSS vers... Overall, missed opportunities for antenatal care were 15.4% of 95% (12.1, 19.1%). Factors such as maternal age being 15-24 (AOR = 6.9, 95% CI: 2.89-8.81); having a college education (AOR = 0.02, 95% C... According to this report, relatively high proportions of pregnant women experienced missed opportunities in antenatal care follow-up. Factors such as maternal age, education, parity, frequency, timing...